GA
HOLX

Geneva Advisors’s Hologic HOLX Stock Holding History

Geneva Advisors’s Portfolio HOLX Stock Details HOLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$759K Sell
16,728
-2,750
-14% -$121K 0.01% 418
2017
Q1 		$829K Sell
19,478
-4,332
-18% -$177K 0.01% 392
2016
Q4 		$955K Sell
23,810
-2,248
-9% -$86.7K 0.02% 350
2016
Q3 		$1.01M Sell
26,058
-2,050
-7% -$77.4K 0.02% 314
2016
Q2 		$973K Sell
28,108
-4,238
-13% -$147K 0.02% 319
2016
Q1 		$1.12M Buy
32,346
+863
+3% +$30.1K 0.02% 279
2015
Q4 		$1.22M Sell
31,483
-1,525
-5% -$59.3K 0.02% 272
2015
Q3 		$1.29M Sell
33,008
-3,600
-10% -$143K 0.03% 260
2015
Q2 		$1.39M Sell
36,608
-250
-0.7% -$8.75K 0.02% 260
2015
Q1 		$1.22M Sell
36,858
-2,955
-7% -$90.7K 0.02% 268
2014
Q4 		$1.06M Sell
39,813
-1,517
-4% -$39.2K 0.02% 281
2014
Q3 		$1.01M Sell
41,330
-2,975
-7% -$75.1K 0.02% 302
2014
Q2 		$1.12M Buy
44,305
+4,550
+11% +$106K 0.02% 292
2014
Q1 		$855K Buy
+39,755
New +$858K 0.02% 310

Other funds holding HOLX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geneva Advisors's HOLX Position: Q2 2017 in Review

Geneva Advisors reduced its Hologic (HOLX) stake by 14% in Q2 2017, selling an estimated $121K and leaving 16,728 shares worth $759K. The position accounts for 0.01% of the portfolio, ranked #418.

Geneva Advisors first reported a position in HOLX in Q1 2014 and has held it in 14 quarters since. The position peaked at $1.39M in Q2 2015. 505 funds tracked by Wall St. Rank hold HOLX as of Q2 2017.

  • Geneva Advisors held 16,728 shares of Hologic worth $759K as of Q2 2017.
  • Geneva Advisors sold 2,750 Hologic shares in Q2 2017, an estimated $121K.
  • Hologic made up 0.01% of Geneva Advisors's portfolio in Q2 2017, its #418 holding.
  • Geneva Advisors first reported a position in Hologic in Q1 2014 and has held it in 14 quarters since.
  • Geneva Advisors's Hologic position peaked at $1.39M in Q2 2015.
  • 505 funds tracked by Wall St. Rank held Hologic as of Q2 2017.

Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.